Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Nature
|
November 19, 2004
Targeted cancer therapy
Charles Sawyers
Cancer Research
|
November 3, 2006
Transgenic mouse model for rapid pharmacodynamic evaluation of antiandrogens
Katharine Ellwood-Yen, John Wongvipat, Charles Sawyers
Oncogene
|
July 26, 2002
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation
Miranda Thomas, Richard Laura, Karin Hepner, et al.
The Prostate
|
November 26, 2009
Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model
Srinivas Nandana, Katharine Ellwood-Yen, Charles Sawyers, et al.
Cancer Genetics
|
August 30, 2011
Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors
Ronald L Paquette, John Nicoll, Meenal Chalukya, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 16, 2006
Gene expression changes associated with progression and response in chronic myeloid leukemia
Jerald P Radich, Hongyue Dai, Mao Mao, et al.
Blood
|
November 18, 2005
Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance
Joya Chandra, Jeannette Tracy, David Loegering, et al.
Science Advances
|
February 7, 2025
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
Ninghui Mao, Young Sun Lee, Nazifa Salsabeel, et al.
Kidney International
|
June 8, 2019
Disruption of MAGI2-RapGEF2-Rap1 signaling contributes to podocyte dysfunction in congenital nephrotic syndrome caused by mutations in MAGI2
Bingbing Zhu, Aili Cao, Jianhua Li, et al.
JCO Clinical Cancer Informatics
|
August 7, 2020
Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data Pooling
Stacy Thomas, Tara Lichtenberg, Kristen Dang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Nature
|
November 19, 2004
Targeted cancer therapy
Charles Sawyers
Cancer Research
|
November 3, 2006
Transgenic mouse model for rapid pharmacodynamic evaluation of antiandrogens
Katharine Ellwood-Yen, John Wongvipat, Charles Sawyers
Oncogene
|
July 26, 2002
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation
Miranda Thomas, Richard Laura, Karin Hepner, et al.
The Prostate
|
November 26, 2009
Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model
Srinivas Nandana, Katharine Ellwood-Yen, Charles Sawyers, et al.
Cancer Genetics
|
August 30, 2011
Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors
Ronald L Paquette, John Nicoll, Meenal Chalukya, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 16, 2006
Gene expression changes associated with progression and response in chronic myeloid leukemia
Jerald P Radich, Hongyue Dai, Mao Mao, et al.
Blood
|
November 18, 2005
Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance
Joya Chandra, Jeannette Tracy, David Loegering, et al.
Science Advances
|
February 7, 2025
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
Ninghui Mao, Young Sun Lee, Nazifa Salsabeel, et al.
Kidney International
|
June 8, 2019
Disruption of MAGI2-RapGEF2-Rap1 signaling contributes to podocyte dysfunction in congenital nephrotic syndrome caused by mutations in MAGI2
Bingbing Zhu, Aili Cao, Jianhua Li, et al.
JCO Clinical Cancer Informatics
|
August 7, 2020
Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data Pooling
Stacy Thomas, Tara Lichtenberg, Kristen Dang, et al.
Page
of 2